{Reference Type}: Journal Article
{Title}: Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate Lowering Therapy Guidelines for People With CKD.
{Author}: Stanley IK;Phoon RKS;Toussaint ND;Cullen V;Kearns J;Dalbeth N;Johnson DW;Krishnasamy R;Tunnicliffe DJ; ;
{Journal}: Kidney Int Rep
{Volume}: 7
{Issue}: 12
{Year}: Dec 2022
{Factor}: 6.234
{DOI}: 10.1016/j.ekir.2022.09.024
{Abstract}: <B>UNASSIGNED: </B>The slow transformation of new research findings into clinical guidelines is a barrier to providing evidence-based care. The Caring for Australians and New Zealanders with Kidney Impairment (CARI) guidelines are developing models to improve guideline production, one methodology involves more functional concordance between trial groups, such as the Australian Kidney Trials Network (AKTN) and CARI. The objective of this project was to rapidly produce an evidence-based guideline on urate-lowering therapy in patients with chronic kidney disease (CKD), in response to new clinical trial publications on the topic by the AKTN.<BR><B>UNASSIGNED: </B>To produce a guideline as rapidly as possible, an existing systematic review was utilized as the evidence base, and then updated with the inclusion of clinical trials that had been published subsequently. A Work Group was convened to review the evidence and compose an appropriate guideline using CARI/GRADE methodology. The group met 3 times over 45 days to formulate the guideline.<BR><B>UNASSIGNED: </B>The result was a strong recommendation against the use urate-lowering therapies in individuals with CKD (not receiving dialysis) and asymptomatic hyperuricemia. The process of identifying an appropriate existing systematic review, updating the literature search, and synthesizing the evidence, was done by 2 individuals over 15 days. The Work Group was formulated and composed the guideline over 45 days. In all, a new guideline incorporating the most up-to-date evidence was formulated in 60 days.<BR><B>UNASSIGNED: </B>This method of guideline development represents a potentially new way of releasing guidelines that encapsulates all available evidence in a time-efficient manner.